I reported previously (four times) on Israel’s Neuroderm and its innovative treatments for Parkinson’s sufferers.  Neuroderm has just been bought by Japan’s Mitsubishi Tanabe for $1.1 billion – a record for an Israeli life-science company. It should bring products to market faster.

http://www.timesofisrael.com/israeli-drug-maker-neuroderm-sold-to-japanese-pharma-giant-for-1-1b/